Kobat et al in the development of atherosclerosis. Br Heart J. 1993;69(1 Suppl):S38-41. 3. Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868-874. 4. Cunningham KS, Gotlieb AI. The role of shear stress in the pathogenesis of atherosclerosis. Lab Invest. 2005;85(1):9-23. 5. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab. 2002;13(2):84-89. 6. Ahima RS, Osei SY. Adipokines in obesity. Front Horm Res. 2008;36:182-197. 7. Fantuzzi G, Mazzone T. Adipose tissue and atheroscle- rosis: exploring the connection. Arterioscler Thromb Vasc Biol. 2007;27(5):996-1003. 8. Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, Hashimoto I, et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci U S A. 2005;102(30):10610-10615. 9. Youn BS, Kloting N, Kratzsch J, Lee N, Park JW, Song ES, Ruschke K, et al. Serum vaspin concentra- tions in human obesity and type 2 diabetes. Diabetes. 2008;57(2):372-377. 10. El-Mesallamy HO, Kassem DH, El-Demerdash E, Amin AI. Vaspin and visfatin/Nampt are interesting interrelat- ed adipokines playing a role in the pathogenesis of type 2 diabetes mellitus. Metabolism. 2011;60(1):63-70. 11. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253. J Clin Med Res • 2012;4(2):110-113 12. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999;340(2):115-126. 13. Van Harmelen V, Reynisdottir S, Eriksson P, Thorne A, Hoffstedt J, Lonnqvist F, Arner P. Leptin secretion from subcutaneous and visceral adipose tissue in women. Di- abetes. 1998;47(6):913-917. 14. Moller DE. Potential role of TNF-alpha in the patho- genesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab. 2000;11(6):212-217. 15. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I. Production of plasminogen activator in- hibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabe- tes. 1997;46(5):860-867. 16. Fried SK, Bunkin DA, Greenberg AS. Omental and sub- cutaneous adipose tissues of obese subjects release inter- leukin-6: depot difference and regulation by glucocorti- coid. J Clin Endocrinol Metab. 1998;83(3):847-850. 17. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409(6818):307- 312. 18. Aust G, Richter O, Rohm S, Kerner C, Hauss J, Klot- ing N, Ruschke K, et al. Vaspin serum concentra- tions in patients with carotid stenosis. Atherosclerosis. 2009;204(1):262-266. 19. Kadoglou NP, Gkontopoulos A, Kapelouzou A, Fotia- dis G, Theofilogiannakos EK, Kottas G, Lampropoulos S. Serum levels of vaspin and visfatin in patients with coronary artery disease-Kozani study. Clin Chim Acta. 2011;412(1-2):48-52. Articles © The authors | Journal compilation © J Clin Med Res and Elmer Press™ | www.jocmr.org 113